Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, looks back on the first year of OneOncology and discusses what's to come in the next year.
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, looks back on the first year of OneOncology and discusses what's to come in the next year.
Transcript
Looking back on the first year of OneOncology, how has the partnership impacted both providers and patients?
The first year of OneOncology has been a tremendous growth opportunity for us as we’ve learned our core practices and we’ve learned how the patients flow and how the operations piece works, so we’ve now integrated a lot of the functions, particularly on the operational side so that there’s this smooth and consistent way operations are being done and the technology has been aligned.
We have the same OncoEMR system for our [electronic health record], we have the same billing system now the same revenue cycle management, enterprise management. So that now is standardized and we’re now focusing on the clinical piece, and we’ve spent a lot of time over the last 6 months figuring out where the pressure points are on our clinical enterprise and how we bring the practices together.
One of the things that’s been amazing to be is there’s so much excitement and so much expertise that varies from our practices and bringing all that together elevates all of our practices. So, we’re working now on pathways and we hope to hope a unified pathway component going forward into 2020. We’re very excited about a research network that we’ve heard from all of our partners is really important so that we can improve clinical access to clinical trials and to have more trials participate. There’s so many great drugs being evaluated now, we just need more access and we’re hearing from our manufacturers, we’re hearing from our practices, we’re hearing from patients, “Give us more opportunities,” so that’s a high priority for us in the next year as we move forward.
We’re working on a whole number of quality and value initiatives and each of these are a committee that we formed as part of our overarching leadership council called OneCouncil. Soo, we’ve established the operational piece now in the first year and moving full force into the clinical piece.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More